HOME >> MEDICINE >> NEWS
Genetic amplification (NAAT) test detects HIV more effectively than standard tests in urban study

ATLANTA Adding a new HIV screening method, called nucleic acid amplification testing (NAAT), to standard HIV testing, researchers were able to uncover six percent more cases of HIV infection in urban STD and drug treatment clinics and HIV testing sites in Atlanta than with standard HIV antibody tests alone. The research will be presented at the 12th Conference on Retroviruses and Opportunistic Infections in Boston on February 25, 2005 by Frances Priddy, MD, assistant professor of medicine at Emory University School of Medicine.

Physician/researchers at Emory, the University of North Carolina at Chapel Hill and the Georgia Department of Human Resources used NAAT to screen clients receiving routing HIV testing and counseling at the urban clinics between October 2002 and January 2004. The research team used both standard antibody testing and NAAT testing to screen specimens from 2,202 people who had not previously tested positive for HIV. Sixty-six of the specimens were found to be HIV antibody positive and 2,135 were HIV antibody negative using standard tests. Using NAAT, however, four of the antibody-negative specimens tested positive for HIV viral genes.

On further examination, three of those four individuals were found to have definite acute HIV infections, although only one showed clinical symptoms. One of the four individuals had unclear results and may have had either acute or chronic HIV. In addition, three of the four individuals had HIV viruses with multidrug resistance. The fourth sample was unable to be tested for resistance.

Although standard tests that measure antibody response to the HIV virus have become increasingly sensitive, cases of HIV are occasionally missed because individuals can have negative antibody tests during the early stages of infection. Also, a few people with long-term HIV infection may have false-negative antibody tests or may be chronic carriers who are clinically asymptomatic. The NAAT test helps
'"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University Health Sciences Center
25-Feb-2005


Page: 1 2

Related medicine news :

1. Genetics important in age-related macular degeneration
2. Genetically targeted therapies create opportunities to do business in new ways
3. Genetic testing can identify ischemic and nonischemic heart failure
4. Genetics testing saves health care dollars
5. Genetic mutation linked to infant lung disease
6. Genetic switch proves two mechanisms exist by which immune system cells differentiate
7. Genetic risks for disease often missing from patient charts
8. Genetics of familial atrial fibrillation revealed, Science researchers report
9. Genetic variant may impact smoking cessation
10. Genetics in clinical practice: a revolutionary approach
11. Genetic variant reduces immune response, yet protects against atherosclerosis

Post Your Comments:
(Date:5/22/2013)... 2013, Paris, France: Results from a large ... question whether bivalirudin is superior to heparin ... similar 30-day mortality in patients with non-ST ... percutaneous coronary intervention (PCI)., European and US ... an alternative to unfractionated heparin plus GP ...
(Date:5/22/2013)... In the past decade, more than 500,000 ... with donated uniforms, shoes, balls and other equipment, thanks ... with manufacturers to provide youth with sporting goods. Now, ... in sports and fitness equipment over 10 years, as ... physical activity. , An inaugural donation of 500 ...
(Date:5/22/2013)... Kincardine, Ontario, CA (PRWEB) May 22, 2013 ... Meltdown Challenge, the fitness franchise Fit Body ... its 2nd Annual 1,000 lb. Meltdown Challenge starting on ... located at Davidson Centre 601 Durham Street, Kincardine, Ontario.     ... goal is to inspire and motivate local community residents ...
(Date:5/22/2013)... May 22, 2013 AvePoint ... solutions for social enterprise collaboration platforms, today announced ... firm based in Chicago, Ill. The agreement will ... and provide best-in-class solutions for SharePoint deployments, enabling ... , AvePoint’s DocAve Software Platform and ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Poor adherence ... in not only medical complications and death (some 125,000 ... drug non-adherence), but increased health-care costs. It’s been estimated ... admissions are related to poor medication adherence — a ... billion annually. , Indeed, so dire is the degree ...
Breaking Medicine News(10 mins):Health News:Registry questions superiority of bivalirudin over heparin 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 3Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 2Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 3Health News:Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance 2
(Date:5/21/2013)... Massachusetts , 21. Mai 2013 /PRNewswire/ ... („OSI"), die die Firmen OMNIlife science® Inc., Enztec ... zählt, hat zwei neue, erfahrene Mitglieder in ... , eine erfahrene Führungspersönlichkeit aus der ... David Johnson , anerkannter ...
(Date:5/21/2013)... May 21, 2013  LCA-Vision Inc. (NASDAQ: LCAV ... the Lasik Plus ® brand, announces that all nominees to ... at today,s annual meeting of stockholders.  These Directors are: ... President of Bahl & Gaynor Investment Counsel , ... , Edgar F. Heizer III , ...
(Date:5/21/2013)... 21, 2013  Decision Resources, one of ... for pharmaceutical and healthcare issues, finds that ... key efficacy endpoints, including overall survival and ... influence over surveyed U.S. and European oncologists, ... HER2-negative breast cancer. The two novel emerging ...
Breaking Medicine Technology:Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 2Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 3LCA-Vision Reports on Annual Meeting of Stockholders 2LCA-Vision Reports on Annual Meeting of Stockholders 3LCA-Vision Reports on Annual Meeting of Stockholders 4Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2
Cached News: